Study finds Return on Equity boosts profit growth for pharmaceutical companies
Profit growth in pharmaceutical companies is influenced by Return On Assets (ROA), Return On Equity (ROE), and Net Profit Margin (NPM). A study on Indonesian pharmaceutical firms from 2016-2020 found that ROA does not impact profit growth, ROE positively affects profit growth, and NPM does not negatively impact profit growth.